Abstract
Pancreatic lipid and fatty acid composition was determined in streptozotocin-induced diabetic rats and compared to control and insulin-treated diabetic rats. A pronounced decrease of total fatty acids was recorded and mainly accounted for by a drop of fatty acids in glycerides. Cholesterol, on the other hand, was significantly increased two- to three-fold, leading to an elevated cholesterol/phospholipid ratio. Morpho-cytochemical studies confirmed these findings because the multiple lipid droplets present in acinar cells of diabetic animals were found to be of cholesterol nature. The major alterations in phospholipid-fatty acid composition were characterized by an increase of linoleate coupled to a decrease of monounsaturates and arachidonate, suggesting defective metabolism of saturates and of linoleate. This was further supported by fatty acid ratios that suggested low Δ5 and Δ9 desaturation. Daily administration of insulin for 10 days restored and overcorrected the various lipid alterations. This study suggests that there are alterations in lipid composition and metabolism in the exocrine pancreas of chronic streptozotocin-induced diabetic rats. Their possible role in the mechanism regulating pancreatic function and secretion remains to be elucidated.
Similar content being viewed by others
Abbreviations
- CE:
-
cholesterol ester
- DG:
-
diglyceride
- EDTA:
-
ethylenediamine tetraacetic acid
- FA:
-
fatty acid
- FC:
-
free cholesterol
- HDL:
-
high density lipoprotein
- MG:
-
monoglyceride
- LDL:
-
low density lipoprotein
- PL:
-
phospholipid
- TC:
-
total cholesterol
- TG:
-
triglyceride
References
Domschke, W., Tympner, F., Domschke, S., and Demling, L. (1975)Dig. Dis. 20, 309–312.
Chey, W.Y., Shay, H., and Shuman, C.R. (1963)Ann. Intern. Med. 59, 812–821.
Vacca, J.B., Henke, W.J., and Knight, W.A. (1964)Am. Intern. Med. 61, 242–247.
Korc, M., Iwamoto, Y., Sankaran, H., Williams, J.A., and Goldfine, I.D. (1981)Am. J. Physiol. 240, G56-G62.
Korc, M., Owerbach, D., Quinto, C., and Rutter, W.J. (1981)Science 213, 351–353.
Soling, H.D., and Unger, K.O. (1972)Eur. J. Clin. Invest. 2, 199–212.
Gregoire, S., and Bendayan, M. (1986)Diabetologia 29, 655–660.
Bendayan, M., Ito, S., and Manocchio, I. (1982)Diabetologia 23, 65–68.
Williams, J.A., and Godfine, I.D. (1986)Diabetes 34, 980–986.
Balk, M.V., Max Lang, C., White, W.J., and Munger, B.L. (1975)Lab. Invest. 32, 28–32.
Seemayer, T.A., Colle, E., Tannenbaum, G.S., Oligny, L.L., Guttman, R.D., and Goldman, H. (1983)Metabolism 32, 26–32.
Gepts, W., and De Mey, J. (1978)Diabetes 27 (Suppl. 1), 251–261.
Bendayan, M., and Gregoire, S. (1987)Pancreas 2, 272–282.
Henderson, J.R. (1969)Lancet 2, 469–470.
Hellerstrom, C., Hellman, B., Bralin, S., and Larsson, S. (1962)Acta Pathol. Microbiol. Scand. 54, 1–7.
Bierman, E.L., Bagdade, J., and Porte, D. Jr. (1966)Trans. Assoc. Am. Phys. 79, 348–360.
Reaven, E.P., and Reaven, G.M. (1974)J. Clin. Invest. 54, 1167–1178.
Schrade, W., Boehle, E., Biegler, R., and Harmuth, E. (1962)Lancet 2, 285–290.
Holman, R.T., Johnson, S.B., Gerrard, J.M., Mauer, S.M., Kupcho-Sandberg, S., and Brown, D.M. (1983)Proc. Natl. Acad. Sci. USA 80, 2375–2379.
Peluffo, R.O., Ayala, S., and Brenner, R.R. (1970)Am. J. Physiol. 218, 669–673.
Brasitus, T.A., and Dudeja, P.K. (1985)J. Biol. Chem. 260, 12405–12409.
Anderson, L.C., and Garret, J.R. (1986)Arch. Oral Biol. 31, 469–475.
Folch, J., Lees, M., and Sloane Stanely, G.H. (1957)J. Biol. Chem. 226, 497–509.
Lepage, G., and Roy, C.C. (1986)J. Lipid Res. 27, 114–120.
Frühling, J., Penasse, W., Sand, G., and Claude, A. (1969)J. Microscop. 8, 857–982.
Bancroft, T.A. (1968) inTopics in Intermediate Statistical Methods, 1st edn., The Iowa State University Press, Ames, IA.
Rudney, H., and Sexton, R.C. (1986)Ann. Rev. Nutr. 6, 245–272.
Feingold, K.R., Wiley, N.H., MacRae, G., Moser, A.H., Lear, S.D., and Siperstein, M.D. (1982)Diabetes 31, 388–395.
Feingold, K.R., and Moser, A.H. (1984)Am. J. Physiol., G494–G501.
Young, N.L., Saudek, C.D., and Crawford, S.A. (1982)J. Lipid Res. 23, 266–275.
Grundy, S.M. (1984)J. Lipid Res. 25, 1611–1618.
Chen, Y.D.I., Kraemer, F.B., and Reaven, G.M. (1980)J. Biol. Chem. 255, 9162–9167.
Gepts, W. (1965)Diabetes 14, 619–633.
Dandona, P., Freedman, D.B., Foo, Y., Perkins, J., Katrak, A., Mikhailidis, D.P., Rosalki, S.B., and Beckett, A.G. (1984)J. Clin. Pathol. 37, 302–306.
Foulis, A.K., and Stewart, J.A. (1984)Diabetologia 26, 456–461.
Orci, L. (1976) inDiabetes Research Today, pp. 135–151, Schaltaner Verlag, New York.
Benjamin, W., and Gellhorn, A. (1966)J. Lipid Res. 7, 285–294.
Brenner, R.R., Peluffo, R.O., Mercuri, O., and Restelli, M.A. (1968)Am. J. Physiol. 215, 63–70.
Holman, R.T., Johnson, S.B., and Hatch, T.F. (1982)Am. J. Clin. Nutr. 35, 617–623.
Author information
Authors and Affiliations
About this article
Cite this article
Levy, E., Roy, C.C., Lepage, G. et al. Lipid abnormalities in pancreatic tissue of streptozotocin-induced diabetic rats. Lipids 23, 771–778 (1988). https://doi.org/10.1007/BF02536220
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536220